Send the following on WhatsApp
Continue to ChatBreast cancer, early stage, first results from the BELLINI trial, Analysis of ADAPT and ADAPTcycle trials, Gruppo Italiano Mammella (GIM) end-of-study results https://oncoletter.ch/video-archiv/breastcancer/esmo-2022-interviews-von-renate-haidinger-brustkrebs-deutschland-e-v-kopie.html